These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 1703559)
1. In vivo protective effect of tumour necrosis factor alpha against experimental infection with herpes simplex virus type 1. Rossol-Voth R; Rossol S; Schütt KH; Corridori S; de Cian W; Falke D J Gen Virol; 1991 Jan; 72 ( Pt 1)():143-7. PubMed ID: 1703559 [TBL] [Abstract][Full Text] [Related]
2. Enhanced lysis of herpes simplex virus type 1-infected mouse cell lines by NC and NK effectors. Colmenares C; Lopez C J Immunol; 1986 May; 136(9):3473-80. PubMed ID: 2420891 [TBL] [Abstract][Full Text] [Related]
3. The role of natural killer cells and interferon in resistance to acute infection of mice with herpes simplex virus type 1. Bukowski JF; Welsh RM J Immunol; 1986 May; 136(9):3481-5. PubMed ID: 2420892 [TBL] [Abstract][Full Text] [Related]
4. Activation of NK cells in mice following corneal infection with herpes simplex virus type-1. Brandt CR; Salkowski CA Invest Ophthalmol Vis Sci; 1992 Jan; 33(1):113-20. PubMed ID: 1370438 [TBL] [Abstract][Full Text] [Related]
5. In vivo significance of NK cell on resistance against virus (HSV-1) infections in mice. Habu S; Akamatsu K; Tamaoki N; Okumura K J Immunol; 1984 Nov; 133(5):2743-7. PubMed ID: 6207244 [TBL] [Abstract][Full Text] [Related]
6. Autocrine secretion of interferon-alpha/beta and tumour necrosis factor-alpha synergistically activates mouse macrophages after infection with herpes simplex virus type 2. Ellermann-Eriksen S J Gen Virol; 1993 Oct; 74 ( Pt 10)():2191-9. PubMed ID: 8409942 [TBL] [Abstract][Full Text] [Related]
7. Experimental infection of inbred mice with herpes simplex virus. II. Interferon production and activation of natural killer cells in the peritoneal exudate. Engler H; Zawatzky R; Goldbach A; Schröder CH; Weyand C; Hämmerling GJ; Kirchner H J Gen Virol; 1981 Jul; 55(Pt 1):25-30. PubMed ID: 6170726 [TBL] [Abstract][Full Text] [Related]
8. Induction of innate immunity against herpes simplex virus type 2 infection via local delivery of Toll-like receptor ligands correlates with beta interferon production. Gill N; Deacon PM; Lichty B; Mossman KL; Ashkar AA J Virol; 2006 Oct; 80(20):9943-50. PubMed ID: 17005672 [TBL] [Abstract][Full Text] [Related]
9. Herpes simplex virus type 1 alters transcript levels of tumor necrosis factor-alpha and interleukin-6 in retinal glial cells. Drescher KM; Whittum-Hudson JA Invest Ophthalmol Vis Sci; 1996 Oct; 37(11):2302-12. PubMed ID: 8843914 [TBL] [Abstract][Full Text] [Related]
11. Acute morphine administration reduces white blood cells' capability to induce innate resistance against HSV-1 infection in BALB/c mice. Jamali A; Bamdad T; Soleimanjahi H; Pakdel FG; Arefian E Neuroimmunomodulation; 2007; 14(1):16-23. PubMed ID: 17700036 [TBL] [Abstract][Full Text] [Related]
12. Injection of anti-thy-1.2 serum breaks genetic resistance of mice against herpes simplex virus. Chmielarczyk W; Engler H; Ernst R; Opitz U; Kirchner H J Gen Virol; 1985 May; 66 ( Pt 5)():1087-94. PubMed ID: 2582081 [TBL] [Abstract][Full Text] [Related]
13. NK and NKT cell-independent contribution of interleukin-15 to innate protection against mucosal viral infection. Gill N; Rosenthal KL; Ashkar AA J Virol; 2005 Apr; 79(7):4470-8. PubMed ID: 15767447 [TBL] [Abstract][Full Text] [Related]
14. Protection of mice by an apathogenic strain HSV-1 against lethal infection by a pathogenic strain of HSV-1. Schröeder CH; Engler H; Kirchner H J Gen Virol; 1981 Jan; 52(Pt 1):159-61. PubMed ID: 6267173 [TBL] [Abstract][Full Text] [Related]
15. Virus-cell interactions regulating induction of tumor necrosis factor alpha production in macrophages infected with herpes simplex virus. Paludan SR; Mogensen SC J Virol; 2001 Nov; 75(21):10170-8. PubMed ID: 11581385 [TBL] [Abstract][Full Text] [Related]
16. Protection by polyI:polyC against infection with herpes simplex virus in mice pretreated with Corynebacterium parvum. Storch E; Baumgartl D; Kirchner H Nat Immun Cell Growth Regul; 1983-1984; 3(3):134-42. PubMed ID: 6209572 [TBL] [Abstract][Full Text] [Related]
17. Protection of neonatal mice against herpes simplex virus infection: probable in vivo antibody-dependent cellular cytotoxicity. Kohl S; Loo LS J Immunol; 1982 Jul; 129(1):370-6. PubMed ID: 6282968 [TBL] [Abstract][Full Text] [Related]
18. Mast cells play a key role in host defense against herpes simplex virus infection through TNF-α and IL-6 production. Aoki R; Kawamura T; Goshima F; Ogawa Y; Nakae S; Nakao A; Moriishi K; Nishiyama Y; Shimada S J Invest Dermatol; 2013 Sep; 133(9):2170-9. PubMed ID: 23528820 [TBL] [Abstract][Full Text] [Related]
19. Experimental infection of inbred mice with herpes simplex virus type 1. I. Investigation of humoral and cellular immunity and of interferon induction. Zawatzky R; Hilfenhaus J; Marcucci F; Kirchner H J Gen Virol; 1981 Mar; 53(Pt 1):31-8. PubMed ID: 6168735 [TBL] [Abstract][Full Text] [Related]
20. Induction of natural killer cells by herpes-simplex virus type 2 in resistant and sensitive inbred mouse strains. Armerding D; Rossiter H Immunobiology; 1981; 158(4):369-79. PubMed ID: 6263793 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]